Efficacy Medical Treatment as an Alternative to surgical treatment in Management of Infantile Hypertrophic Pyloric Stenosis (IHPS)
Journal Title: Journal of Pediatrics & Child Care - Year 2018, Vol 4, Issue 1
Abstract
Background: Background: Pyloromyotomy is considered the main surgical management for treatment of Infantile Hypertrophic Pyloric Stenosis(IHPS). Medical treatment with atropine therapy for management IHPScould be even more beneficial than open surgery and laparoscopic pyloromyotomy mainly in infants with major congenital anomaly orcomorbid conditions and in cases of refusal of patients to perform surgery to the infants. Aims: To evaluate and assess the values and efficacy of atropineas a non-surgical alternative to pyloromyotomy in management of IHPSand to investigate the sonographic changes of the pyloric canal, thebenefits and adverse effects of atropine, with special consideration to improvement of pyloric hypertrophy. Patients and methods: we have included 25 infants with clinical and sonographic evidences of having IHPS. We give them intravenous atropine at a dose of 0.01 mg/kg 6 times daily before feeding. When vomiting decreased and they became able to take oral formula of about 150 ml/kg/day; we gradually increased the feeding volume then we gave them oral atropine 0.02 mg/kg six times a day and then we decreased the dose was gradually and we noticed and reported improvements. Results: we found that 20 (80%) of our included 25 infants have stopped projectile vomiting after intravenous atropine treatment in a median time of 7 days and then oral atropine intake followed for about median 44 days. We proved that there are no significant complications occurred from atropine treatment. Ultra-sonography revealed that there was a significant decrease in pyloric muscle thickness, but there was no significant shortening of the pyloric canal after termination of the medical treatment with atropine. At presentation, our in included infants exhibited failure to thrive, but they were thriving at 6 months of age (p < 0.01). The remaining 5 infants were not improved with IV atropine and they required surgery 4 infants of them showed a dramatic improvement of vomiting after surgery (p < 0.01). Conclusions: in IHPS medical treatment with atropine resulted in a clinical recovery and a significant reduction in pyloric muscle thickness, so that this therapy is an effective alternative to pyloromyotomy if the length of the hospital stay and the need of continuing oral atropine medication are accepted by the parents of the infants.
Authors and Affiliations
Omar Atef Elekiabi
Keywords
Related Articles
- EP ID EP486949
- DOI 10.13188/2380-0534.1000025
- Views 101
- Downloads 0
Dextrocardia with Situs Inversus, Atrio-ventricular and Ventriculararterial Concordance and a Left Posterior Aorta in a Preterm Twin Neonate
In dextrocardia, the main base-apex cardiac axis is directed to the right side of the chest. The majority of dextrocardia is associated with situs solitus and either normally related or L-transposed great vessels. Dextro...
Phelan-McDermid Syndrome Presenting as a Puzzling Case of Regressive Autism
Phelan-McDermid Syndrome is a genetic neurodevelopmental disorder characterized by intellectual disability, severe speech delay, hypotonia and autism spectrum disorder (ASD). Variable dysmorphic features are also describ...
Neonatal Hypotension, the Role of Hydrocortisone and Other Pharmacological Agents in its Management
Neonatal hypotension remains one of the most commonly encountered problems in neonatal intensive care units. Pharmacologic agents used in the management of neonatal hypotension include volume expanders, inotropes and vas...
Preschool Developmental Screening with Denver II Test in Semi-Urban Areas
The first few years of life have a crucial role in development and provide a time window when a supportive and stimulating environment can be most effective, and conversely when adverse factors can cause more pervasive d...
Experience of Intravenous Levetiracetam in Acute Repetitive Seizures in Children: Case Series from a Single Tertiary Center
Background: Intravenous levetiracetam (LEV) has been reported to be well tolerated and effective in treating status epilepticus and acute repetitive seizures in children. Compared with traditional anticonvulsants, LEV ha...